Literature DB >> 18178790

Managing CKD: key therapeutic issues introduction.

Stuart L Linas1.   

Abstract

Mesh：

Year:  2008        PMID： 18178790      PMCID： PMC3152268          DOI： 10.2215/CJN.03240807

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  12 in total

Review 1.  Renal dysfunction as a novel risk factor: microalbuminuria and cardiovascular risk.

Authors:  Eberhard Ritz
Journal:  Kidney Int Suppl       Date:  2005-01       Impact factor: 10.545

2.  Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

Authors:  V J Dzau
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

3.  Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study.

Authors:  Toshiharu Ninomiya; Yutaka Kiyohara; Michiaki Kubo; Yumihiro Tanizaki; Yasufumi Doi; Ken Okubo; Yoshiyuki Wakugawa; Jun Hata; Yoshinori Oishi; Kentaro Shikata; Koji Yonemoto; Hideki Hirakata; Mitsuo Iida
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

4.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

5.  Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy.

Authors:  Robert C Atkins; Esther M Briganti; Julia B Lewis; Lawrence G Hunsicker; Gregory Braden; Paul J Champion de Crespigny; Giacomo DeFerrari; Paul Drury; Francesco Locatelli; Thomas B Wiegmann; Edmund J Lewis
Journal:  Am J Kidney Dis       Date:  2005-02       Impact factor: 8.860

6.  The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.

Authors:  Janice Lea; Tom Greene; Lee Hebert; Michael Lipkowitz; Shaul Massry; John Middleton; Stephen G Rostand; Edgar Miller; Winifred Smith; George L Bakris
Journal:  Arch Intern Med       Date:  2005-04-25

7.  Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study.

Authors:  Jerome L Abramson; Claudine T Jurkovitz; Viola Vaccarino; William S Weintraub; William McClellan
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

8.  Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

Authors:  Dick de Zeeuw; Giuseppe Remuzzi; Hans-Henrik Parving; William F Keane; Zhongxin Zhang; Shahnaz Shahinfar; Steve Snapinn; Mark E Cooper; William E Mitch; Barry M Brenner
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

9.  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.

Authors:  J C Peterson; S Adler; J M Burkart; T Greene; L A Hebert; L G Hunsicker; A J King; S Klahr; S G Massry; J L Seifter
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

10.  Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael A Farber; Stanley Franklin; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carole Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391
View more
  1 in total

1.  Caring for Patients with CRF: Rewards and Benefits.

Authors:  Ayman Karkar
Journal:  Int J Nephrol       Date:  2011-04-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.